Interestingly, though several breast cancer susceptibility genes including TP53 and CHEK2 have been historically thought to play a role in breast cancer through rare, highly penetrant mutations in coding regions, our study provides evidence that common variants in these genes which modulate expression also impact breast cancer etiology. This evidence concerns the gene CHEK2 and breast cancer.